17-34581134-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001304438.2(TMEM132E):c.58C>T(p.Leu20Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000287 in 1,521,218 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001304438.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM132E | NM_001304438.2 | c.58C>T | p.Leu20Phe | missense_variant | 1/9 | ENST00000631683.2 | NP_001291367.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM132E | ENST00000631683.2 | c.58C>T | p.Leu20Phe | missense_variant | 1/9 | 5 | NM_001304438.2 | ENSP00000487800.2 | ||
TMEM132E | ENST00000321639.7 | c.58C>T | p.Leu20Phe | missense_variant | 1/10 | 5 | ENSP00000316532.5 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152146Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000168 AC: 20AN: 119070Hom.: 0 AF XY: 0.000243 AC XY: 16AN XY: 65756
GnomAD4 exome AF: 0.000283 AC: 388AN: 1369072Hom.: 1 Cov.: 34 AF XY: 0.000323 AC XY: 218AN XY: 675874
GnomAD4 genome AF: 0.000322 AC: 49AN: 152146Hom.: 0 Cov.: 34 AF XY: 0.000296 AC XY: 22AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 29, 2023 | The c.58C>T (p.L20F) alteration is located in exon 1 (coding exon 1) of the TMEM132E gene. This alteration results from a C to T substitution at nucleotide position 58, causing the leucine (L) at amino acid position 20 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 11, 2024 | This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 20 of the TMEM132E protein (p.Leu20Phe). This variant is present in population databases (rs774898682, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with TMEM132E-related conditions. ClinVar contains an entry for this variant (Variation ID: 1414121). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Not Available". The phenylalanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at